Clinic
Geisinger Jersey Shore Hospital
Geisinger Jersey Shore Hospital was paid $2.17M by Medicaid between Jan 2020 and Dec 2024, across 127 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.
33Billing provider infoGEISINGER JERSEY SHORE HOSPITAL
JERSEY SHORE, PA 17740
JERSEY SHORE, PA 17740
33aNPI1366407587assigned 04/19/2006
33bProvider typeClinic/Center
28Total paid$2.17M
24GClaims69,942
24DCodes billed127
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Pennsylvania
Rank by total paid#52 of 176
Median peer was paid$441K
This provider vs. median4.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MULL, CINDY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 6,388 | $190K | |
| 2021 | 29,847 | $792K | |
| 2022 | 10,267 | $301K | |
| 2023 | 13,094 | $475K | |
| 2024incomplete | 10,346 | $409K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 4,467 | 4,272 | $356K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 3,386 | 3,292 | $355K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 5,797 | 5,592 | $341K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 14% | 3,551 | 3,408 | $304K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.7% | 970 | 947 | $79K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.0% | 324 | 322 | $64K |
| 80053 | Comprehensive metabolic panel | 2.4% | 4,749 | 4,546 | $53K |
| 87481 | 2.3% | 722 | 620 | $50K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.2% | 1,726 | 1,660 | $48K |
| 0100U | 1.7% | 87 | 86 | $36K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 6,171 | 5,891 | $34K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.3% | 716 | 697 | $28K |
115 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 839 | $26K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 247 | $24K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 1,077 | $23K |
| 0002A | <1% | 576 | $21K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,064 | $19K |
| 0001A | <1% | 587 | $19K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 684 | $17K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 619 | $15K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 676 | $13K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 607 | $12K |
| 80061 | Lipid panel | <1% | 963 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,290 | $10K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,022 | $10K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 126 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 739 | $9K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 220 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 916 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 654 | $8K |
| 83605 | <1% | 1,016 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 910 | $7K |
| 84484 | <1% | 776 | $7K | |
| 84702 | <1% | 436 | $7K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 189 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 338 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 85 | $5K |
| 81001 | <1% | 1,510 | $4K | |
| 0012A | <1% | 151 | $4K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 239 | $4K |
| 83690 | <1% | 835 | $4K | |
| 76830 | Ultrasound, transvaginal | <1% | 55 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 142 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 27 | $4K |
| 85027 | <1% | 622 | $4K | |
| 0004A | <1% | 82 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 97 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 564 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,787 | $3K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 37 | $3K |
| 97161 | <1% | 51 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 98 | $3K |
| 73630 | <1% | 167 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 19 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 25 | $2K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 65 | $2K |
| 73610 | <1% | 86 | $2K | |
| 76642 | <1% | 28 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 279 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 141 | $2K |
| 84439 | <1% | 236 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 57 | $2K |
| 0011A | <1% | 89 | $2K | |
| 83880 | <1% | 63 | $1K | |
| 82248 | <1% | 246 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 28 | $1K |
| 87631 | <1% | 12 | $1K | |
| 87186 | <1% | 190 | $1K | |
| 87150 | <1% | 12 | $1K | |
| 0064A | <1% | 29 | $1K | |
| 73130 | <1% | 81 | $1K | |
| 73110 | <1% | 73 | $1K | |
| 85610 | <1% | 321 | $1K | |
| 93971 | <1% | 12 | $1K | |
| 83735 | <1% | 222 | $1K | |
| 86803 | <1% | 56 | $1K | |
| 73564 | <1% | 33 | $1K | |
| 80076 | <1% | 122 | $936.16 | |
| 0072A | <1% | 21 | $924.00 | |
| 81025 | <1% | 286 | $915.60 | |
| 0071A | <1% | 20 | $880.00 | |
| 81003 | <1% | 306 | $857.15 | |
| 82805 | <1% | 29 | $851.08 | |
| 82607 | <1% | 71 | $786.50 | |
| 86140 | <1% | 247 | $625.80 | |
| 87077 | <1% | 71 | $578.30 | |
| 82570 | <1% | 92 | $549.46 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 613 | $545.84 |
| 80305 | <1% | 42 | $405.87 | |
| 87340 | <1% | 25 | $374.16 | |
| 82043 | <1% | 51 | $360.00 | |
| 82728 | <1% | 32 | $343.20 | |
| 83655 | <1% | 31 | $341.00 | |
| 86850 | <1% | 40 | $315.35 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,008 | $308.42 |
| 86901 | <1% | 59 | $284.04 | |
| 86900 | <1% | 59 | $280.45 | |
| 84146 | <1% | 12 | $264.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 44 | $261.45 |
| 85007 | <1% | 60 | $247.28 | |
| 85379 | <1% | 29 | $244.86 | |
| 97035 | <1% | 40 | $241.50 | |
| 83540 | <1% | 29 | $223.20 | |
| 82962 | <1% | 135 | $200.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,207 | $156.93 |
| 85652 | <1% | 66 | $154.80 | |
| 87040 | <1% | 13 | $137.20 | |
| 84100 | <1% | 39 | $129.78 | |
| 83550 | <1% | 28 | $126.50 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 904 | $122.71 |
| 82375 | <1% | 29 | $122.64 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,985 | $107.43 |
| 86592 | <1% | 24 | $101.20 | |
| J2704 | Injection, propofol, 10 mg | <1% | 591 | $94.10 |
| 87070 | <1% | 14 | $91.08 | |
| 83050 | <1% | 29 | $65.70 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 26 | $60.42 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 58 | $40.10 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 153 | $3.60 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 326 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 215 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 124 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 21 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 203 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 96 | $0.00 |
| 90715 | 0% | 14 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMULL, CINDY (SYSTEM DIRECTOR CREDENENROLLMENTS)
| Provider | Location | Paid |
|---|---|---|
| Geisinger Clinic | Danville, PA | $74.54M |
| Community Medical Center | Scranton, PA | $22.62M |
| Geisinger Clinic | Danville, PA | $14.93M |
| West Shore Advanced Life Support Services, INC. | Danville, PA | $4.41M |
| Geisinger Clinic | Pottsville, PA | $3.39M |
| Geisinger Clinic | Lewistown, PA | $2.93M |
| Geisinger Clinic | Scranton, PA | $2.63M |
| Geisinger Clinic | Wilkes Barre, PA | $2.35M |
| Geisinger Clinic | Danville, PA | $2.28M |
| Geisinger Clinic | Scranton, PA | $1.71M |
| Geisinger Clinic | Tunkhannock, PA | $1.11M |
| Geisinger Clinic | Orwigsburg, PA | $974K |
| Geisinger Clinic | Pittston, PA | $942K |
| Geisinger Clinic | Berwick, PA | $896K |
| Geisinger Clinic Selinsgrove | Selinsgrove, PA | $819K |
| Geisinger Clinic | Philipsburg, PA | $678K |
| Geisinger Clinic | Lewisburg, PA | $557K |
| Geisinger Clinic | Mountain Top, PA | $523K |
| Geisinger Clinic | Kulpmont, PA | $489K |
| Geisinger Clinic | Frackville, PA | $479K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.